A less controversial option than aducanumab may be available soon to help individuals with mild to moderate Alzheimer’s disease-related dementia. Researchers at the Medical University of Vienna and the University of Toronto have developed a technique using ultrasound that reverses cognitive decline and they say it could be available for clinical use shortly.